Pharmacologically active heteroaryl substituted imidazo (4,5-c)

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546118, A61K 3144, C07D47104

Patent

active

049905180

ABSTRACT:
This invention relates to substituted imidazopyridine derivatives having the follow formula ##STR1## or a pharmaceutically acceptable acid addition salt thereof: wherein the variables are described in the specification are useful in the treatment of diseases or disorders mediated by platelet-activating factor. This invention also relates to pharmaceutical compositions of such substituted imidazopyridines.

REFERENCES:
patent: 4327100 (1982-04-01), Austel et al.
patent: 4336257 (1982-06-01), Baldwin
patent: 4716160 (1981-12-01), Markwell et al.
patent: 4804658 (1989-02-01), Manley
patent: 4914108 (1990-04-01), Khanna et al.
EP Application 87 113 294.0, Published Mar. 23, 1988.
EP Application 87 114 979.5, Published Apr. 20, 1988.
EP Application 87 114 841.7, Published May 18, 1988.
EP Application 83302433.4, Published Nov. 9, 1983.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmacologically active heteroaryl substituted imidazo (4,5-c) does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmacologically active heteroaryl substituted imidazo (4,5-c) , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmacologically active heteroaryl substituted imidazo (4,5-c) will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-10640

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.